Kyowa Kirin Co.,Ltd.

4151

TSE PrimePharmaceuticals

¥ -

You can review earnings summary, quarterly trends, full-year progress, and detailed income statement data.

descriptionIncome Statement (PL) Summary

Updated: 2026-08-03FY2026 Q2

Revenue

5298100M JPY

YoY +7.4%

Operating Income

YoY -

Net Income

813.4100M JPY

YoY +111.7%

EPS

58.5JPY

YoY +87.6%

Performance Trend

Revenue, operating income and net income trend (last 5 periods)

RevenueOperatingNet Income

4968.3億円

3726.2億円

2484.1億円

1242.1億円

Rev: 3522.5億円Op: -NI: 523.5億円

Rev: 3983.7億円Op: -NI: 535.7億円

Rev: 4422.3億円Op: -NI: 811.9億円

Rev: 4955.6億円Op: -NI: 598.7億円

Rev: 4968.3億円Op: -NI: 670.4億円

2021/FY2022/FY2023/FY2024/FY2025/FY

Full-Year Progress

FY2026 Q2

Net Income-

Revenue Progress2636.300M

Revenue Forecast520000M

Net Income Progress306.200M

Net Income Forecast-

Income Statement Details

Unit: JPY

Unlock Long-Term Financial Data

Your current plan allows viewing financial data for the latest 1 year (annual only). Upgrade to the Standard Plan to view up to 3 years (including quarterly data), or the Premium Plan to access all historical data.

Standard Plan Premium Plan